Pharmacological Inhibition of Lipid Import and Transport Proteins in Ovarian Cancer
Lisa Lemberger(Medical University of Vienna), Thomas W. Grunt(Comprehensive Cancer Center Vienna)
Cited by 10
Related Papers
Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells
|International Journal of Cancer|1995|70
Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells
|International Journal of Cancer|2014|62